Sustained Virologic Response Decreases Serum Markers of Angiogenesis,Inflammation,and Fibrosis in HIV/HCV-Coinfected Patients on Hepatitis C Virus Therapy
Restricted accessLetterFirst published online March, 2011
Sustained Virologic Response Decreases Serum Markers of Angiogenesis,Inflammation,and Fibrosis in HIV/HCV-Coinfected Patients on Hepatitis C Virus Therapy
Mendes-CorreaMC, WidmanA, BrussiML, GuastiniCF, GianiniRJ. Incidence and predictors of severe liver fibrosis in HIV-infected patients with chronic hepatitis C in Brazil. AIDS Patient Care STDs, 2008; 22:701–707.
2.
GrahamCS, BadenLR, YuEet al.Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis. Clin Infect Dis, 2001; 33:562–569.
3.
ScottJD, WaldA, KitahataMet al.Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population. AIDS Patient Care STDs, 2009; 23:925–929.
4.
PolS, SorianoV. Management of chronic hepatitis C virus infection in HIV-infected patients. Clin Infect Dis, 2008; 47:94–101.
5.
AronsohnA, ReauN. Long-term outcomes after treatment with interferon and ribavirin in HCV patients. J Clin Gastroenterol, 2009; 43:661–671.
6.
DienstagJL. The role of liver biopsy in chronic hepatitis C. Hepatology, 2002; 36,5 Suppl 1:S152–160.
7.
KelleherTB, AfdhalN. Assessment of liver fibrosis in co-infected patients. J Hepatol, 2006; 44,Suppl 1:S126–S31.
ItohY, OkanoueT, OhnishiNet al.Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection. Am J Gastroenterol, 1999; 94:1332–1340.
Rodriguez-TorresM, Rodriguez-OrengoJF, Rios-BedoyaCFet al.Effect of hepatitis C virus treatment in fibrosis progression rate (FPR) and time to cirrhosis (TTC) in patients co-infected with human immunodeficiency virus: A paired liver biopsy study. J Hepatol, 2007; 46:613–619.
13.
ResinoS, MicheloudD, MirallesPet al.Diagnosis of advanced fibrosis in HIV and hepatitis C virus-coinfected patients via a new noninvasive index: The HGM-3 index. HIV Med, 2010; 11:64–73.
14.
MarraF, BertolaniC. Adipokines in liver diseases. Hepatology, 2009; 50:957–969.
15.
FontanaRJ, BonkovskyHL, NaishadhamDet al.Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis. Clin Gastroenterol Hepatol, 2009; 7:219–226.
16.
Vespasiani-GentilucciU, GalatiG, MazzarelliCet al.Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection. J Interferon Cytokine Res(in press).
17.
ZografosTA, RigopoulouEI, LiaskosCet al.Alterations of leptin during IFN-alpha therapy in patients with chronic viral hepatitis. J Hepatol, 2006; 44:848–855.
